Liquidia Technologies LQDA 深 滬
等待開盤 07-25 09:30:00 美东时间
18.77
+1.020
+5.75%
華盛通- 最 高18.97
- 今 開17.76
- 成交量 330.38万股
- 最 低 17.68
- 昨 收 17.75
- 總市值 16.05亿
- 52周最高 19.41
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 8.26
- 委 比 68.30%
- 總股本 8548.45万
- 歷史最高 38.46
- 量 比 1.23
- 振 幅 7.27%
- 歷史最低 2.25
- 每 手 1
- 風險率 2.33%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多100倍潜力股？Opendoor股价触底疯涨500%，如何在暴涨前寻找下一只“Meme股”黑马？
散户蜂拥晒单买入，投资大佬Jackson建仓看涨Opendoor至82美元！作为普通投资者，如何在暴涨前寻找下一只“Meme股”黑马？>>
07-22 14:34
Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA) and Centene (CNC)
Companies in the Healthcare sector have received a lot of coverage today as ana...
07-02 14:40
Liquidia Technologies Appoints Dana Boyle as Chief Accounting Officer
Liquidia Technologies ( ($LQDA) ) has issued an update. On July 1, 2025, Liquid...
07-02 04:50
Janus Henderson Small/Mid Cap Growth Alpha ETF declares quarterly distribution of $0.1260
Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD) - $0.126003. Payable Jul 07; for shareholders of record Jun 30; ex-div Jun 30. More on The Trade Desk's Amazon Threat Is Misguided TD Bank: 2025's...
06-30 22:54
Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™
Liquidia Corporation received an additional $50 million under its sixth amendment to its financing agreement with Healthcare Royalty (HCRx), following the denial of United Therapeutics’ request for a preliminary injunction against Liquidia and the first commercial sale of YUTREPIA™ (treprostinil) inhalation powder. YUTREPIA is indicated for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstit...
06-23 20:34
美股周涨跌榜 | 周涨33%！普拉格能源与乌兹别克斯坦达成50亿美元交易；核能股Oklo周内累涨26%
普拉格能源：周内累涨33%，与乌兹别克斯坦达成50亿美元交易；Oklo Inc：周内累涨26%，获得国防部核反应堆合同。
06-14 10:25
美股大行评级 | 潜在涨幅超50%，数十家机构大幅上调甲骨文目标价！
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1140203048973164544.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Maxim Group：上调Datavault AI(DVLT)评级至"买入"，目标价3美元</p> <p>• 蒙特利尔银行：维持DoubleVerify Holdings(DV)"跑赢大市"评级，目标价从25美元升至26
06-13 09:33
Wells Fargo Maintains Overweight on Liquidia, Raises Price Target to $25
Wells Fargo analyst Tiago Fauth maintains Liquidia (NASDAQ:LQDA) with a Overweight and raises the price target from $23 to $25.
06-12 21:08
Analysts’ Top Healthcare Picks: Liquidia Technologies (LQDA), Cabaletta Bio (CABA)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts jus...
06-12 15:20
Liquidia, United Therapeutics fall after mid-stage data for Insmed’s PAH asset
Insmed (NASDAQ:INSM) announced Tuesday that TPIP, its experimental therapy for pulmonary arterial hypertension, succeeded in a mid-stage trial, sending the shares of its rivals Liquidia (NASDAQ:LQDA) ...
06-10 19:58
